Six years of qualification
Audited Supplier
In This Store
Changzhou Comwin Fine Chemicals Co., Ltd. is a member of Comwin International Company Limited. ComWin Fine Chemicals, founded in 2003, is located in Changzhou, a beautiful historical and cultural city with a thousand years' history. Its manufacturing facility is situated in Huangyan. We mainly produce and market some active pharmaceutical ingredients and its intermediates. Strong Products: Gemfibrozil, Meloxicam, Sulpiride, Levosulpiride, Marbofloxacin, Praziquantel
Since its establishment, ComWin has been a CMO business partner for European customers. Moving Forward, ComWin concentrates on developing more and more product ranges (food & animal healthcare products) for the customers worldwide.
Market Coverage: Brazil, Colombia, France, Germany, Hungary, Indonesia, Israel, Italy, Japan, Korea, Myanmar, Poland, South Africa, Thailand, USA
Main Customers: Sanofi, Boehringer-ingelheim, Vetoquinol, IMCD
Year of Establishment: 2003
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 10-50
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages: International logistics services is our highlighted strengths, such as cold-chain, hazardous shipment, door to door which we've been providing to our overseas customers.
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight June 2024: Globalization on the Go
![2-(4-Fluorophenyl)-5-[(5-iodo-2-Methylphenyl)methyl]thiophene](https://eimg.pharmasources.com/image/20201022/vYKMjDaFVT3GsN26L4K1qBQCGYBMw4DDXgwENVGd.jpeg!200)
![(1s-trans)-2-[(phenylmethoxy)methyl]-3-cyclopenten-1-ol](https://eimg.pharmasources.com/image/20201027/mQOZpTu2RcWxkwUCYfj8gd78rIt00coii51qL78P.jpeg!200)
![8-Chloro-5,10-dihydrodibenzo[b,e][1,4]diazepin-11-one](https://eimg.pharmasources.com/image/20201012/zadLmZ8qYL6Ubj6frEzDvqgQjuvQdyUuAEXWpI4o.jpeg!200)
